eISSN: 1509-572x
ISSN: 1641-4640
Folia Neuropathologica
Current issue Archive Manuscripts accepted About the journal Abstracting and indexing Subscription Contact Instructions for authors
SCImago Journal & Country Rank
Original paper

Frequency and topography of small cerebrovascular lesions in vascular and in mixed dementia: a post-mortem 7-tesla magnetic resonance imaging study with neuropathological correlates

Jacques De Reuck, Florent Auger, Nicolas Durieux, Vincent Deramecourt, Claude-Alain Maurage, Charlotte Cordonnier, Florence Pasquier, Didier Leys, Regis Bordet

Folia Neuropathol 2017; 55 (1): 31-37
Article file
- Frequency.pdf  [0.25 MB]


Mixed dementia (MixD) refers to a combination of definite Alzheimer’s disease (AD) and vascular encephalopathy. The distinction between MixD and “pure” vascular dementia is controversial [15,23]. In demented patients vascular lesions on structural magnetic resonance imaging (MRI) are often misdiagnosed as probable vascular dementia (VaD) as compared to autopsy-confirmed diagnosis [20]. Also the utility of their detection for the individual diagnosis of VaD or MixD is limited [28]. Major vascular lesions differ between VaD and MixD [17].
An important obstacle in the standardization of diagnosis is the fact that vascular brain lesions are a large group comprising heterogeneous changes that have different pathogenesis [14]. Our previous post-mortem study showed that the lesion pattern in VaD and MixD is different: while the global severity of the white matter changes is more or less similar, lacunes in the corona radiata predominate in the former and cerebral amyloid angiopathy-related lesions in the latter [9].
So there is a need to quantify and determine the topography of the different types of cerebrovascular lesions in VaD and MixD. Post-mortem MRI is an additional complement of the neuropathological assessment of these lesions [21]. 7-tesla MRI is the most suitable technique to detect small cerebrovascular lesions in post-mortem brains [26].
The present post-mortem 7.0-tesla MRI study with neuropathological correlates investigates whether there are differences in severity and topography of small cerebrovascular lesions between VaD and MixD brains in order to find neuroimaging criteria that allow the distinction between both disease entities.

Material and methods

Out of a series of 162 consecutive autopsied pa­tients, followed up at the Lille University Hospital, who underwent a MRI examination, according to the neuropathological criteria [2,4], 14 with a diagnosis of VaD, 24 of MixD and 11 control brains, without a history of dementia or stroke, were selected.
They all underwent a post-mortem 7.0-tesla MRI examination of 3 coronal sections of a cerebral hemisphere and one horizontal section of a cerebellar hemisphere, followed by an extensive histological examination of the brain samples.
Previously obtained informed consent of the pa­tients or from the nearest family allowed an autopsy for diagnostic and scientific purposes. The brain tissue samples were acquired from the Lille Neuro-Bank of the Lille University that is a part of the “Centres des Resources Biologiques” and acts as an institutional review board.
One fresh cerebral hemisphere was frozen for biochemical examination. The remaining hemisphere, the brainstem, and most of the cerebellum were fixed in formalin for three weeks.

Neuropathological examination

The disease diagnosis was made according a standard procedure and examination of a large number of samples. In addition to the detection of macroscopic visible lesions such as haematomas, territorial and lacunar infarcts (LIs), a whole coronal section of a cerebral hemisphere, at the level of the mammillary body and a horizontal section of a cerebellar hemisphere were taken for the semi-quantitative evaluation of the small cerebrovascular lesions such as white matter changes (WMCs), cortical microbleeds (CoMBs), and cortical microinfarcts (CoMIs).
The mean values for WMCs were the average of the ranking scores: no change (R0), a few isolated (R1), frequent scattered in the corona radiata (R2) and forming confluent lesions (R3) of myelin and axonal loss. For the other cerebrovascular lesions, their mean values corresponded to their percentage number [6].
The diagnosis of cerebral angiopathy (CAA) was made when a majority of -amyloid stained vessels were present in at least three of the four examined samples and as not-CAA,  when absent or scarce, in case of a few stained vessels in one or two slides [13].

Magnetic resonance imaging examination

Three coronal sections of a cerebral hemisphere were submitted to T2 and T2* MRI: a frontal one at the level of the head of the caudate nucleus, a central one at the level of the mammillary body and one at the level of the parietal and occipital lobes. In addition, one horizontal section of a cerebellar hemisphere was also examined.
A 7.0-tesla MRI Bruker BioSpin SA with an issuer-receiver cylinder coil of 72 mm inner diameter (Ettlingen, Germany) was used, according to a previous described method [7].
The ranking scores of severity of the WMCs were evaluated separately in the different brain sections as done on the neuropathological section. Lacunar infarcts were defined as small-rounded lesions with a diameter between 3 and 15 mm in the corona radiata, internal capsule, caudate nucleus, putamen, globus pallidus, thalamus and cerebellar white matter [27]. The number and the location of the small cerebrovascular lesions were determined by consensus evaluation of three observers (JDR, FA, ND), blinded to the neuropathological diagnosis. The inter-rater reliability resulted in an interclass correlation coefficient of 0.82.

Statistical analysis

Univariate comparisons of unpaired groups were performed with the Fisher’s exact test for categorical data. The non-parametric Mann-Whitney U-test was used to compare continuous variables. The signi­ficance level, two-tailed, was set at ≤ 0.01 for significant and ≤ 0.001 for highly significant. Values set at ≤ 0.05 but more than > 0.01 were considered as marginal significant and not included as relevant due to the relative small sample sizes.


The average age at death was not significantly different between the groups: 75 (± 10) years in the VaD patients, 76 (± 11) in the MixD and 71 (± 9) in the control group (p = 0.16). Also the gender distribution was similar with 80% males in VaD, 54% in MixD and 73% in the control groups, respectively (p = 0.62).
Arterial hypertension and the use of antithrombotic agents were the only more frequently found clinical vascular risk factors in the VaD and MixD patients compared to the controls (Table I).
On neuropathological examination, the semi- quan­titative evaluation of the degree of severity showed a significant increase in WMCs and higher incidence of CoMIs and CoMBs in VaD as MixD compared to controls. On the other hand, LIs and territorial infarcts were only more frequent in the VaD group, while CAA related lesions were more observed in the MixD group (Table II).
The same findings were observed on the post- mortem MRI, concerning WMCs, LIs, CoMBs and CoMIs (Table III).
On mutual comparison of the VaD and the MixD brain CoMBs, predominated in the frontal lobe and in the cerebellum of the former, while increased in the temporal and the occipital lobes in the latter group (Fig. 1). Cortical microinfarcts predominated in the frontal lobe and the cerebellum of the VaD group, while increased in the occipital lobe of the MixD group (Fig. 2). White matter changes predominated only in the temporal lobe of the MixD group (Fig. 3). As to LIs they were significantly increased in the corona radiata and the putamen in the VaD group (Fig. 4, Table IV).


The present study shows a difference in the distribution and types of the small cerebrovascular lesions in patients with VaD compared to those with MixD. Their heterogeneity was already previously suspected [16,22,25]. Our previous neuropathological study demonstrated that LIs due to arteriosclerotic angiopathy are the most common lesions in VaD, while CAA related lesions are more frequent in MixD, suggesting that the latter represent the natural end-stage evolution of Alzheimer’s disease [9]. There is a strong correlation between CAA and age [17,19]. However, in contrast to a previous neuropathological study [1], more territorial infarcts are observed in VaD than in MixD brains. This is probably due to more additional large-vessel disease in the former group [18].
Cortical microinfarcts predominate in the frontal lobe and in the cerebellum of VaD as cerebral arteriosclerosis is their main cause [8,18], while according to the validated Boston criteria for CAA, they predominate in the occipital lobe in MixD [10]. The same is also observed for CoMBs, although also highly present in the temporal lobe of MixD brains. The latter can be explained by the fact that CoMBs are not only due to micro-vascular lesions, but also to the severity of the neurodegenerative changes themselves in AD [6].
White matter changes are, as a whole, as severe in VaD as in MixD [9]. The present study shows a predominance in the temporal lobe of MixD brains associated to the temporal lobe atrophy, due to the underlying severity of the Alzheimer lesions [3].
Although in our previous study, only LIs in the corona radiata were found in VaD compared to MixD [12], our present study also shows an additional increase in the putamen. Their topography corresponds to the vascular territory of the lenticulostriate arteries [5]. These findings correlate well with “in vivo” measurements of lenticulostriate arteries using 7-tesla MRI that show fewer side-branches in VaD [24].
The present post-mortem MRI study shows clear differences in the distribution and the types of cerebrovascular lesions, confirming that VaD and MixD are different diseases.


Authors report no conflict of interest.


1. Attems J, Jellinger KA. The overlap between vascular disease and Alzheimer’s disease – lessons from pathology. BMC Med 2014; 12: 206.
2. Braak H, Braak E. Evolution of neuronal changes in the course of Alzheimer’s disease. Acta Neuropathol 1991; 82: 239-259.
3. Bombois S, Debette S, Bruander A, Delbeuck X, Delmaire C, Leys D, Pasquier F. Vascular subcortical hyperintensities predict conversion to vascular and mixed dementia in MCI patients. Stroke 2008; 39: 2046-2051.
4. Deramecourt V, Slade JY, Oakley AE, Perry RH, Ince PG, Maurage CA, Kalaria RH. Staging and natural history of cerebrovasular pathology in dementia. Neurology 2012; 78: 1043-1050.
5. De Reuck J. The human periventricular arterial blood supply and the anatomy of cerebral infarctions. Eur Neurol 1971; 5: 321-334.
6. De Reuck J, Deramecourt V, Cordonnier C, Leys D, Pasquier F, Maurage CA. Prevalence of small cerebral bleeds in patients with a neurodegenerative dementia: A neuropathological study. J Neurol Sci 2011; 300: 63-66.
7. De Reuck J, Auger F, Cordonnier C, Deramecourt V, Durieux N, Pasquier F, Bordet R, Maurage CA, Leys D. Comparison of 7.0-T T2*-magnetic resonance imaging of cerebral bleeds in post-mortem brain sections of Alzheimer patients with their neuropathological correlates. Cerebrovasc Dis 2011; 31: 511-517.
8. De Reuck JL, Deramecourt V, Durieux N, Cordonnier C, Devos D, Defebvre L, Moreau C, Capparos-Lefebvre D, Pasquier F, Leys D, Maurage CA, Bordet R. The significance of cortical cerebellar microbleeds and microinfarcts in neurodegenerative and cerebrovascular diseases. A post-mortem 7.0-tesla magnetic resonance study with neuropathological correlates. Cerebrovasc Dis 2015; 39: 138-143.
9. De Reuck J, Deramecourt V, Cordonnier C, Pasquier F, Leys D, Maurage CA, Bordet R. Incidence of post-mortem neurodegenerative and cerebrovascular pathology in mixed dementia. J Neurol Sci 2016; 366: 164-166.
10. De Reuck j, Cordonnier C, Deramecourt V, Auger F, Durieux N, Leys D, Pasquier F, Maurage CA. Lobar intracerebral haematoma. Neuropathological and 7.0-tesla magnetic resonance imaging evaluation. J Neurol Sci 2016; 369: 121-125.
11. De Reuck J, Auger F, Durieux N, Cordonnier C, Deramecourt V, Pasquier F, Maurage CA, Leys D, Bordet R. The topography of cortical microinfarcts in neurodegenerative diseases and vascular dementia: a postmortem 7.0-tesla magnetic resonance imaging study. Eur Neurol 2016; 76: 57-61.
12. De Reuck J, Auger F, Durieux N, Cordonnier C, Deramecourt V, Pasquier F, Maurage CA, Leys D, Bordet R. Topographic distribution of white matter changes and lacunar infarcts in neurodegenerative and vascular dementia syndromes: A post-mortem 7.0-tesla magnetic resonance imaging study. Eur Stroke J 2016; 1: 122-129.
13. Ellis RJ, Olichney JM, Thal LJ, Mirra SS, Morris JC, Beekly D, Heyman A. Cerebral amyloid angiopathy in the brains of patients with Alzheimer’s disease: the CERAD experience, Part XV. Neurology 1996; 46: 1592-1596.
14. Grinberg LT, Heinsen H. Toward a pathological definition of vascular dementia. J Neurol Sci 2010; 299: 136-138.
15. Jellinger KA, Attems J. Neuropathological evaluation of mixed dementia. J Neurol Sci 2007; 25: 80-87.
16. Jellinger KA. The pathology of “vascular dementia”: a critical update. J Alzheimers Dis 2008; 14: 107-123.
17. Jellinger KA, Attems J. Prevalence and pathology of vascular dementia in the oldest-old. J Alzheimers Dis 2010; 21: 1283-1293.
18. Kitagawa K, Miwa K, Yagita Y, Okazaki S, Sakaguchi M, Mochizuki H. Association between carotid stenosis or lacunar infarction and incident dementia in patients with vascular risk factors. Eur J Neurol 2015; 22: 187-192.
19. Kovari E, Herrmann FR, Hof PR, Bouras C. The relation between cerebral amyloid angiopathy and cortical microinfarcts in brain ageing and Alzheimer’s disease. Neuropathol Appl Neurobiol 2013; 39: 498-509.
20. Niemantsverdriet E, Feyen BF, Le Bastard N, Martin JJ, Goeman J, De Deyn PP, Engelborghs S. Overdiagnosing vascular dementia using structural brain imaging for dementia work-up. J Alzheimers Dis 2015; 45: 1039-1043.
21. McAleese KE, Firbank M, Hunter D, Sun L, Hall R, Near JW, Mann DM, Esiri M, Jellinger KA, O’Brien JT, Attems J. Magnetic resonance imaging of fixed post mortem brains reliably reflects subcortical vascular pathology of frontal, parietal and occipital white matter. Neuropathol Appl Neurobiol 2013; 39: 485-497.
22. Lo RY, Jagust WJ; Alzheimer’s Disease Neuroimaging Initiative. Vascular burden and Alzheimer disease pathological progression. Neurology 2012; 79: 1349-1355.
23. Lopez OL, Kuller LH, Becker JT, Jagust WJ, DeKosky ST, Fitzpatrick A, Breitner J, Lyketsos C, Kawas C, Carlson M. Classification of vascular dementia in the Cardiovascular Health Study Cognition Study. Neurology 2005; 64:1539-1547.
24. Seo SW, Kang CK, Kim SH, Yoon DS, Liao W, Worz S, Rohr K, Kim YB, Na DL, Cho ZH. Measurements of lenticulostriate arteries using 7T MRI: new imaging markers for subcortical vascular dementia. J Neurol Sci 2012; 322: 200-205.
25. Staekenborg SS, van Straaten EC, van der Flier WM, Lane R, Barkhof F, Scheltens P. Small vessel versus large vessel vascular dementia: risk factors and MRI findings. J Neurol 2008; 255:1644-1651.
26. Trattnig S, Bogner W, Gruber S, Szomolanyi P, Juras V, Robinson S, Zbyn S, Haneder S. Clinical applications at ultrahigh field (7 T). Where does it make the difference? NMR Biomed 2015; 29: 1316-1334.
27. Wang X, Valdés Hernandez MD, Doubal F, Chappell FM, Piper RJ, Deary IJ, Wardlaw JM. Development and initial evaluation of a semi-automatic approach to assess perivascular spaces on conventional magnetic resonance images. J Neurosci Methods 2015; 257: 34-44.
28. Yassi N, Desmond PM, Masters CL. Magnetic resonance imaging of vascular contributions to cognitive impairment and dementia. J Mol Neurosci 2016; 60: 349-353.
Copyright: © 2017 Mossakowski Medical Research Centre Polish Academy of Sciences and the Polish Association of Neuropathologists. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Quick links
© 2017 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe